- 专利标题： Butyrylcholinesterase inhibitors
-
申请号： US15004797申请日： 2016-01-22
-
公开(公告)号： US09757399B2公开(公告)日： 2017-09-12
- 发明人: Roger A. Acey , Kensaku Nakayama
- 申请人： JAL Therapeutics, LLC
- 申请人地址： US CA Long Beach
- 专利权人： JAL THERAPEUTICS, INC.
- 当前专利权人： JAL THERAPEUTICS, INC.
- 当前专利权人地址： US CA Long Beach
- 代理机构： K&L Gates LLP
- 代理商 Louis C. Cullman
- 主分类号： A61K31/661
- IPC分类号： A61K31/661 ; A61K31/6615 ; A61K9/00 ; C07F9/12 ; C07F9/18 ; C07F9/24
摘要：
Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates.These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
公开/授权文献
- US20160206635A1 Butyrylcholinesterase Inhibitors 公开/授权日：2016-07-21
信息查询
